Overview
- Provides insight into the neuromolecular mechanism of action
- Highlights the use of cannabis in major neurologic and psychiatric disorders
- Explains the recent advances in the understanding of endocannabiniod system
- Offers important knowledge for researchers and clinicians alike .
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1264)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (9 chapters)
-
Front Matter
Keywords
About this book
This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues.
Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Ī9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial.
The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.
Editors and Affiliations
About the editors
Dr. Eric Murillo-RodrĆguez is Psychologist and holds a PhD. in Biomedical Sciences, both degrees obtained by the National Autonomous University of Mexico (UNAM). Upon graduation, he completed his postdoctoral training at Harvard Medical School. His scientific contribution includes over 70 peer-reviewed publications in various reputed scientific and medical journals, 10 chapters in books. He is an active member of several scientific societies and the editorial board members of various journals.
S. R. Pandi-Perumal, MSc, is the President and Chief Executive Officer of Somnogen Canada Inc, a Canadian Corporation. He is a well-recognized sleep researcher and has authored over 200 publications. His general area of research interest includes sleep and biological rhythms. He has edited over 25 volumes dealing with various sleep-related topics.
Jaime Monti, MD, is associated with the University of the Republic, Uruguay. He has completed post-doctoral studies at the National Institute of Health, USA. He is full Professor of Pharmacology and Therapeutic and the School of Medicine of the Republic University, Professor of the Basic Sciences Development Program (PEDECIBA) and Researcher the National Researchers' System. He is a globally recognized sleep researcher and has been awarded with the prestigious Claude Bernard Prize (French Governemnt) and with the Schering Award for Basic Sleep Research (USA). He is an international recognized expert in the neuropharmacology of sleep and wakefulness, with more than two hundred publications in this field.
Bibliographic Information
Book Title: Cannabinoids and Neuropsychiatric Disorders
Editors: Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-030-57369-0
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-57368-3Published: 18 December 2020
Softcover ISBN: 978-3-030-57371-3Published: 19 December 2021
eBook ISBN: 978-3-030-57369-0Published: 17 December 2020
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: XVII, 153
Number of Illustrations: 39 b/w illustrations, 4 illustrations in colour
Topics: Molecular Medicine, Neurosciences